226 related articles for article (PubMed ID: 11684864)
41. Perinatal aspects of inherited thrombophilia.
Bonnar J; Green R; Norris L
Semin Thromb Hemost; 1999; 25(5):481-5. PubMed ID: 10625206
[TBL] [Abstract][Full Text] [Related]
42. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
Breddin HK; Kadziola Z; Scully M; Nakov R; Misselwitz F; Kakkar VV
Thromb Haemost; 2003 Feb; 89(2):272-7. PubMed ID: 12574806
[TBL] [Abstract][Full Text] [Related]
43. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.
Abildgaard U; Sandset PM; Hammerstrøm J; Gjestvang FT; Tveit A
Thromb Res; 2009 Jul; 124(3):262-7. PubMed ID: 19162303
[TBL] [Abstract][Full Text] [Related]
44. Low-molecular-weight heparins for the treatment of deep-vein thrombosis.
Cziraky MJ; Spinler SA
Clin Pharm; 1993 Dec; 12(12):892-9. PubMed ID: 8137606
[TBL] [Abstract][Full Text] [Related]
45. Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation.
Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Akamatsu N; Kishi Y; Makuuchi M
Clin Transplant; 2005 Dec; 19(6):804-9. PubMed ID: 16313329
[TBL] [Abstract][Full Text] [Related]
46. Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring.
Chowdary P; Adamidou D; Riddell A; Aghighi S; Griffioen A; Priest P; Moghadam L; Kelaher N; Huq FY; Kadir RA; Tuddenham EG; Gatt A
Br J Haematol; 2015 Mar; 168(5):719-27. PubMed ID: 25351814
[TBL] [Abstract][Full Text] [Related]
47. [Prevention of thromboembolism with low molecular weight heparin (Fragmin) in obstetrics].
Krauss T; Rath W; Dittmer U; Kuhn W
Z Geburtshilfe Perinatol; 1994 Aug; 198(4):120-5. PubMed ID: 7975797
[TBL] [Abstract][Full Text] [Related]
48. Use of low molecular weight heparin in pregnancy.
Melissari E; Parker CJ; Wilson NV; Monte G; Kanthou C; Pemberton KD; Nicolaides KH; Barrett JJ; Kakkar VV
Thromb Haemost; 1992 Dec; 68(6):652-6. PubMed ID: 1337628
[TBL] [Abstract][Full Text] [Related]
49. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
[TBL] [Abstract][Full Text] [Related]
50. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
51. The rheological changes after cesarean section: The influence of low molecular weight or unfractionated heparin on the rheological properties of blood.
Heilmann L; Rath W; Pollow K; Bick RL
Clin Hemorheol Microcirc; 2007; 37(3):211-8. PubMed ID: 17726250
[TBL] [Abstract][Full Text] [Related]
52. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
Kher A; Bauersachs R; Nielsen JD
Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
[TBL] [Abstract][Full Text] [Related]
53. The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
Schambeck CM; Eberl E; Geisen U; Grossmann R; Keller F
Thromb Haemost; 2001 May; 85(5):782-6. PubMed ID: 11372668
[TBL] [Abstract][Full Text] [Related]
54. Inherited thrombophilias and anticoagulation in pregnancy.
Bowles L; Cohen H
Best Pract Res Clin Obstet Gynaecol; 2003 Jun; 17(3):471-89. PubMed ID: 12787539
[TBL] [Abstract][Full Text] [Related]
55. Prophylactic dosing adjustment in pregnancy based upon measurements of anti-factor Xa levels.
Gyamfi C; Cohen R; Desancho MT; Gaddipati S
J Matern Fetal Neonatal Med; 2005 Nov; 18(5):329-31. PubMed ID: 16390793
[TBL] [Abstract][Full Text] [Related]
56. Prophylactic Dose of Dalteparin in Pregnant Women With History of Venous Thromboembolisms and/or Thrombophilia: Real-World Data.
Novak P; Novak A; Šabović M; Kozak M
Angiology; 2023 Sep; 74(8):783-789. PubMed ID: 36113126
[TBL] [Abstract][Full Text] [Related]
57. Laboratory-monitored fondaparinux and coagulation activity in association with total hip replacement.
Virtanen L; Salmela B; Leinonen J; Lemponen M; Huhtala J; Joutsi-Korhonen L; Lassila R
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):597-603. PubMed ID: 24732174
[TBL] [Abstract][Full Text] [Related]
58. ProCGlobal and endogenous thrombin potential during pregnancy.
Hron G; Kyrle PA; Kaider A; Philipp K; Pabinger I; Kollars M; Eichinger S
Am J Obstet Gynecol; 2010 Nov; 203(5):463.e1-6. PubMed ID: 20598285
[TBL] [Abstract][Full Text] [Related]
59. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
Kario K; Matsuo T; Kodama K; Matsuo M
Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
[TBL] [Abstract][Full Text] [Related]
60. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
Jørgensen M; Broholm R; Bækgaard N
Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
